Schedule 13G/A: Barclays Discloses 4.05% Stake in Everi (EVRI)
Rhea-AI Filing Summary
Barclays PLC filed an Amendment No. 1 to a Schedule 13G disclosing a beneficial ownership stake in Everi Holdings Inc. The filing reports ownership of 3,522,623 shares, representing 4.05% of Everi's outstanding common stock, and states Barclays has sole voting and sole dispositive power over those shares. The filing is presented as ownership of 5 percent or less of the class.
The schedule identifies related entities including Barclays Bank PLC, Barclays Capital Inc and Barclays Capital Securities Ltd as subsidiaries involved with the securities. A certification states the shares are held in the ordinary course of business and not for the purpose of changing control of the issuer.
Positive
- Beneficial ownership of 3,522,623 shares disclosed representing 4.05% of Everi common stock
- Sole voting and sole dispositive power reported for the full position, clarifying control rights
- Certification that holdings are in the ordinary course of business and not held to change control
- Identification of related subsidiaries (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) provides transparency
Negative
- None.
Insights
TL;DR: Barclays holds a non-controlling 4.05% stake (3.52M shares) in Everi, reported as held in the ordinary course of business.
The filing documents a 3,522,623 share position equal to 4.05% of Everi common stock with sole voting and dispositive authority. Because the position is reported as 5% or less and characterized as held in the ordinary course, it does not signal an attempt to influence control based on the filing text. The disclosure is material as a public institutional stake but below thresholds that would trigger different regulatory or strategic implications.
TL;DR: Ownership is documented and classified; below 5% and certified not for control, implying routine institutional holding.
The schedule identifies Barclays PLC as the reporting person with sole voting and dispositive power for 3,522,623 shares. It lists specific Barclays subsidiaries associated with the acquisition. The filing includes a certification that the holdings are not intended to change or influence issuer control. From a governance perspective, this is a transparent, routine disclosure of a non-controlling institutional stake.